Effect of inhaled furosemide on Functional Residual Capacity (FRC) in Very Low Birth Weight(VLBW) infants with Bronchopulmonary Dysplasia (BPD)

S. Bowling, K. Williamson, E. Gozum, Cynthia (Cindy) McEvoy

Research output: Contribution to journalArticle

Abstract

In patients with asthma, inhaled furosemide has been shown to decrease the bronchoconstrictive effects of exercise, cold air hyperventilation ,and antigen challenge. Recently inhaled furosemide has been tested in intubated VLBW infants at a dose of 1 mg/kg. No one has reported the effect of inhaled furosemide on FRC in infants with BPD, not has a higher dose of 3 mg/kg of inhaled furosemide been evaluated. We conducted a randomized , double blind crossover study in 18 patients with BPD (requiring oxygen supplementation at 28 days and chest x-ray changes) with each serving as their own control. The infants had a mean birth weight = 863 g; gestational age = 25.8 wks; postnatal age = 67d ; FIO2=27.4%. Six of the infants were intubated at time of study. Each was randomized to receive an aerosol dose of furosemide (3 mg/kg in 2 ml of saline) or furosemide (1 mg/kg in 2ml of saline) or placebo (2 ml of saline) on 3 consecutive days of study. Pulmonary mechanics were measured pre, 1, and 2 hours after the inhalation . FRC was measured with the nitrogen washout technique. A minimum of two measurements were performed with the neonate supine and quiet. A study was acceptable if the measurement had a coefficient of variation (CV) of <10%. In the infants that were intubated, respiratory compliance was measured with the single breath occlusion technique (SensorMedics 2600). A minimum of 10 breaths with a CV of0.05 for all measures There was no significant change in respiratory compliance measurements pre, 1, or 2 hours after treatment with furosemide at 1 mg/kg or 3 mg/kg. There was no difference in the response between intubated and extubated patients. In this population of VLBW infants with BPD,a single dose of 1mg/kg or 3mg/kg of inhaled furosemide does not improve FRC or respiratory compliance.

Original languageEnglish (US)
JournalJournal of Investigative Medicine
Volume47
Issue number2
StatePublished - Feb 1999
Externally publishedYes

Fingerprint

Functional Residual Capacity
Bronchopulmonary Dysplasia
Very Low Birth Weight Infant
Furosemide
Compliance
Time and Motion Studies
Hyperventilation
Mechanics
Aerosols
Double-Blind Method
Birth Weight
Cross-Over Studies
Inhalation
Gestational Age
Nitrogen
Thorax
Asthma
Air
Placebos
X-Rays

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{3dd9b6b0fe2a4535893419558524f3e4,
title = "Effect of inhaled furosemide on Functional Residual Capacity (FRC) in Very Low Birth Weight(VLBW) infants with Bronchopulmonary Dysplasia (BPD)",
abstract = "In patients with asthma, inhaled furosemide has been shown to decrease the bronchoconstrictive effects of exercise, cold air hyperventilation ,and antigen challenge. Recently inhaled furosemide has been tested in intubated VLBW infants at a dose of 1 mg/kg. No one has reported the effect of inhaled furosemide on FRC in infants with BPD, not has a higher dose of 3 mg/kg of inhaled furosemide been evaluated. We conducted a randomized , double blind crossover study in 18 patients with BPD (requiring oxygen supplementation at 28 days and chest x-ray changes) with each serving as their own control. The infants had a mean birth weight = 863 g; gestational age = 25.8 wks; postnatal age = 67d ; FIO2=27.4{\%}. Six of the infants were intubated at time of study. Each was randomized to receive an aerosol dose of furosemide (3 mg/kg in 2 ml of saline) or furosemide (1 mg/kg in 2ml of saline) or placebo (2 ml of saline) on 3 consecutive days of study. Pulmonary mechanics were measured pre, 1, and 2 hours after the inhalation . FRC was measured with the nitrogen washout technique. A minimum of two measurements were performed with the neonate supine and quiet. A study was acceptable if the measurement had a coefficient of variation (CV) of <10{\%}. In the infants that were intubated, respiratory compliance was measured with the single breath occlusion technique (SensorMedics 2600). A minimum of 10 breaths with a CV of0.05 for all measures There was no significant change in respiratory compliance measurements pre, 1, or 2 hours after treatment with furosemide at 1 mg/kg or 3 mg/kg. There was no difference in the response between intubated and extubated patients. In this population of VLBW infants with BPD,a single dose of 1mg/kg or 3mg/kg of inhaled furosemide does not improve FRC or respiratory compliance.",
author = "S. Bowling and K. Williamson and E. Gozum and McEvoy, {Cynthia (Cindy)}",
year = "1999",
month = "2",
language = "English (US)",
volume = "47",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Effect of inhaled furosemide on Functional Residual Capacity (FRC) in Very Low Birth Weight(VLBW) infants with Bronchopulmonary Dysplasia (BPD)

AU - Bowling, S.

AU - Williamson, K.

AU - Gozum, E.

AU - McEvoy, Cynthia (Cindy)

PY - 1999/2

Y1 - 1999/2

N2 - In patients with asthma, inhaled furosemide has been shown to decrease the bronchoconstrictive effects of exercise, cold air hyperventilation ,and antigen challenge. Recently inhaled furosemide has been tested in intubated VLBW infants at a dose of 1 mg/kg. No one has reported the effect of inhaled furosemide on FRC in infants with BPD, not has a higher dose of 3 mg/kg of inhaled furosemide been evaluated. We conducted a randomized , double blind crossover study in 18 patients with BPD (requiring oxygen supplementation at 28 days and chest x-ray changes) with each serving as their own control. The infants had a mean birth weight = 863 g; gestational age = 25.8 wks; postnatal age = 67d ; FIO2=27.4%. Six of the infants were intubated at time of study. Each was randomized to receive an aerosol dose of furosemide (3 mg/kg in 2 ml of saline) or furosemide (1 mg/kg in 2ml of saline) or placebo (2 ml of saline) on 3 consecutive days of study. Pulmonary mechanics were measured pre, 1, and 2 hours after the inhalation . FRC was measured with the nitrogen washout technique. A minimum of two measurements were performed with the neonate supine and quiet. A study was acceptable if the measurement had a coefficient of variation (CV) of <10%. In the infants that were intubated, respiratory compliance was measured with the single breath occlusion technique (SensorMedics 2600). A minimum of 10 breaths with a CV of0.05 for all measures There was no significant change in respiratory compliance measurements pre, 1, or 2 hours after treatment with furosemide at 1 mg/kg or 3 mg/kg. There was no difference in the response between intubated and extubated patients. In this population of VLBW infants with BPD,a single dose of 1mg/kg or 3mg/kg of inhaled furosemide does not improve FRC or respiratory compliance.

AB - In patients with asthma, inhaled furosemide has been shown to decrease the bronchoconstrictive effects of exercise, cold air hyperventilation ,and antigen challenge. Recently inhaled furosemide has been tested in intubated VLBW infants at a dose of 1 mg/kg. No one has reported the effect of inhaled furosemide on FRC in infants with BPD, not has a higher dose of 3 mg/kg of inhaled furosemide been evaluated. We conducted a randomized , double blind crossover study in 18 patients with BPD (requiring oxygen supplementation at 28 days and chest x-ray changes) with each serving as their own control. The infants had a mean birth weight = 863 g; gestational age = 25.8 wks; postnatal age = 67d ; FIO2=27.4%. Six of the infants were intubated at time of study. Each was randomized to receive an aerosol dose of furosemide (3 mg/kg in 2 ml of saline) or furosemide (1 mg/kg in 2ml of saline) or placebo (2 ml of saline) on 3 consecutive days of study. Pulmonary mechanics were measured pre, 1, and 2 hours after the inhalation . FRC was measured with the nitrogen washout technique. A minimum of two measurements were performed with the neonate supine and quiet. A study was acceptable if the measurement had a coefficient of variation (CV) of <10%. In the infants that were intubated, respiratory compliance was measured with the single breath occlusion technique (SensorMedics 2600). A minimum of 10 breaths with a CV of0.05 for all measures There was no significant change in respiratory compliance measurements pre, 1, or 2 hours after treatment with furosemide at 1 mg/kg or 3 mg/kg. There was no difference in the response between intubated and extubated patients. In this population of VLBW infants with BPD,a single dose of 1mg/kg or 3mg/kg of inhaled furosemide does not improve FRC or respiratory compliance.

UR - http://www.scopus.com/inward/record.url?scp=33750092701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750092701&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750092701

VL - 47

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 2

ER -